1. Ovarian Cancer Treatment in India - A woman's lifetime risk of dying from ovarian cancer is 1.1 per cent. It is one of the most common cancers in women after breast…

1. CRS + HIPEC Peritoneal Carcinomatosis: Is HIPEC the answer? Ismail Al-Badawi, KFSH&Rc Riyadh, SA 2. Hyperthermic Intraperitoneal Chemotherapy 3. THE PROBLEM IN THE…

Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells Amit Kumar Srivastavaa, Chunhua Hana, Ran Zhaoa, Tiantian Cuia,…

Slide 1 Adjuvant Vitamin E and Ovarian Cancer Alysha Hartman Mentor: Debbie Mustacich, Ph.D. Linus Pauling Institute Oregon State University Slide 2 Outline  Introduction…

Slide 1A Randomized Phase 2 Trial Comparing Efficacy of the Combination of the PARP-inhibitor Olaparib and the Anti-angiogenic Cediranib Against Olaparib Alone in Recurrent…

Slide 1 Unanswered Questions in Primary Treatment of Ovarian Cancer: Controversial Areas Deborah K. Armstrong, M.D. May 29, 2009 Slide 2 Initial Therapy of Ovarian Cancer:…

Slide 1 Major issues: Vaccine development Analysis of tumor genes Synthetic biology and Genome evolution Diagnostic tests Gene therapy, and ELSI-Social, ethical, legal And…

PowerPoint Presentation Romero IL, McCormick A, McEwen et al. 2012. Obstetrics & Gynecology, vol. 119:61-67 Lung cancer is by far the leading cause of cancer death among…

Major issues: Vaccine development Analysis of tumor genes Synthetic biology and Genome evolution Diagnostic tests Gene therapy, and ELSI-Social, ethical, legal And Regulatory…

Unanswered Questions in Primary Treatment of Ovarian Cancer: Controversial Areas Deborah K. Armstrong, M.D. May 29, 2009 Initial Therapy of Ovarian Cancer: Controversial…